综述:幽门螺杆菌管理的实施挑战——从证据到真实世界实践
该专家知情的综述整合文献、国际指南及结构化国际专家优先排序,识别幽门螺杆菌全程管理中的实施相关挑战。治疗选择与患者管理被最一致优先,高影响陷阱包括高耐药背景经验性三联、咨询不足及无升级经验再治疗。
要点
- 治疗选择与患者管理是专家最一致优先的实施领域。
- 高影响陷阱含高耐药区经验性三联、咨询不足、无升级再治疗。
- 诊断、治疗与随访全程存在持续的实施相关障碍。
核心结论
- 反复出现的实施相关挑战仍是幽门螺杆菌最佳管理的重要障碍。
- 结构化专家优先排序提示改进靶点,支持实施导向策略与研究。
研究设计与样本
- 专家知情的综述,整合相关文献、国际指南文件与结构化国际专家优先排序。
- 初步陷阱清单经文献回顾、临床经验及协调作者与部分共同作者讨论形成。
- 采用中位分进行相对优先排序。
主要发现
- 治疗选择与患者管理是参与专家最一致优先的领域。
- 高影响陷阱包括高耐药背景下的经验性三联治疗。
- 高影响陷阱包括患者咨询不足。
- 高影响陷阱包括无升级的经验性再治疗。
- 诊断、治疗与随访领域亦识别出额外挑战,显示全程持续实施障碍。
临床怎么用
- 在高耐药背景避免经验性三联治疗。
- 加强患者咨询以减少实施差距。
- 避免无升级的经验性再治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite increasingly refined diagnostic strategies and regularly updated treatment guidelines, real-world outcomes of Helicobacter pylori management remain variable. Antimicrobial resistance alone does not fully explain these discrepancies, suggesting important challenges in the implementation of evidence-based care. AIMS: To identify recurring implementation-related challenges across the Helicobacter pylori care pathway and highlight priorities for improving real-world management. METHODS: This expert-informed review integrated relevant literature, international guideline documents, and structured international expert prioritisation. An initial list of implementation-related pitfalls was developed through literature review, clinical experience, and discussions among the coordinating authors and selected co-authors. Twenty-six experts from five continents participated in a structured consultation process and rated predefined pitfalls using a 5-point Likert scale. Median scores were used for relative prioritisation. RESULTS: Treatment selection and patient management emerged as the domains most consistently prioritised by participating experts. High-impact pitfalls included empirical triple therapy in high-resistance settings, inadequate patient counselling, and empirical retreatment without escalation. Additional challenges were identified across diagnostic, treatment, and follow-up domains, highlighting persistent implementation-related barriers throughout the care pathway. CONCLUSIONS: Recurring implementation-related challenges remain important barriers to optimal Helicobacter pylori management. Structured expert prioritisation highlights potential targets for improvement and supports further research and implementation-focused strategies to improve delivery of care.
引用
- Quach DT, Liou JM, Gisbert JP, et al. Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice. Aliment Pharmacol Ther. 2026. PMID: 42310251. doi:10.1111/apt.70798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。